
Gnubiotics is a biotechnology company focused on developing novel glycopeptide therapeutics to address unmet medical needs in oncology and other diseases. Their proprietary GENESIS platform…

Gnubiotics is a biotechnology company focused on developing novel glycopeptide therapeutics to address unmet medical needs in oncology and other diseases. Their proprietary GENESIS platform…
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week
The Company: Gnubiotics Sciences SA is a Swiss biotechnology company developing glycopeptide-based innovations for microbiome health. (Gnubiotics.com) We are preparing the commercial launch of our first brand
AMObiome Forte for companion nanimals, to the veterinary channel. Launch is planned for Q3 2026 with the lead market Portugal. AMObiome Forte is a novel, patent protected glycopeptide complex clinically proven to protect, restore and maintain a healthy microbiome in cats and dogs. AMObiome is FDA approved and free for sale in the EU, UK and Switzerland.
The Position : Gnubiotics is looking to hire a highly capable Brand Launch & Veterinary Channel Manager to lead the launch preparation and in-market execution starting with the lead market followed by European expansion in 2027.
This is a high-impact role requiring a commercially strong, scientifically credible professional who understands the companion animal veterinary channel and knows how to translate science into commercial traction.
You will work closely with leadership and external commercial partners to help drive:
We are looking for someone with relevant experience in the veterinary or animal health industry, ideally in Lisbon, Portugal or Madrid, Spain , with fluent in skills in Portuguese and English (Spanish is a plus) .
This is a hands-on role with real ownership and direct influence on the product’s success from day one.